Syncom Formulations (India) Ltd Surges in Stock Market, Hits New Highs
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been performing exceptionally well in the stock market. Its stock has gained 7.34% on September 6th and has consistently risen for the last 3 days, reaching a new 52-week and all-time high. With a 'Buy' call from MarketsMojo and strong investor confidence, the company is expected to continue its upward momentum and deliver returns for its investors.
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been making waves in the stock market with its recent performance. On September 6th, the company's stock gained 7.34%, outperforming the sector by 7.41%. This positive trend has been consistent for the last 3 days, with the stock rising 19.93% in that period.
The company's stock has also hit a new 52-week and all-time high of Rs.23.99, which is a significant milestone for the company. This strong performance has caught the attention of MarketsMOJO, who have given a 'Buy' call for the stock.
Intraday trading saw the stock reach a high of Rs.23.99, a 7.97% increase from the previous day. This is a clear indication of the company's upward momentum and investor confidence.
Syncom Formulations (India) Ltd is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive sign for the company's future.
In comparison to the Sensex, Syncom Formulations (India) Ltd has outperformed with a 1-day performance of 7.83% and a 1-month performance of 56.50%. This shows the company's strong growth potential and its ability to deliver returns for its investors.
With its recent performance and positive outlook, Syncom Formulations (India) Ltd is definitely a stock to watch out for in the pharmaceutical industry. Investors can expect continued growth and success from this smallcap company.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
